A clinical study to evaluate the effects of a fat cell targeted gel for body skin laxity
| ISRCTN | ISRCTN11066382 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN11066382 |
| Sponsor | Adipeau Inc. |
| Funder | Adipeau Inc. |
- Submission date
- 09/02/2026
- Registration date
- 13/02/2026
- Last edited
- 13/02/2026
- Recruitment status
- Recruiting
- Overall study status
- Ongoing
- Condition category
- Skin and Connective Tissue Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year
Plain English summary of protocol
Plain English summary of protocol not provided at time of registration
Contact information
Mr Ivan Galanin
Public, Scientific, Principal investigator
Public, Scientific, Principal investigator
8 East 96th Street
New York
10128
United States of America
| 0000-0002-8991-9552 | |
| Phone | +1 718-750-1492 |
| ivan@adipeau.com |
Study information
| Primary study design | Interventional | |
|---|---|---|
| Allocation | N/A: single arm study | |
| Masking | Open (masking not used) | |
| Control | Uncontrolled | |
| Assignment | Single | |
| Purpose | Treatment | |
| Scientific title | A clinical study to validate the laxity reduction effects of a dual-acting lipolytic/adipogenic gel | |
| Study objectives | This study will evaluate whether a gel that improves the fitness of skin fat cells can improve the appearance of weak skin on the legs and buttocks. The study aims to demonstrate improvement in laxity severity at Week 12 compared to baseline. | |
| Ethics approval(s) | Ethics approval not required | |
| Health condition(s) or problem(s) studied | Healthy adults | |
| Intervention | Strength Gel (Adipeau Inc), a marketed topical cosmetic containing Kaempferia Parviflora Extract as an active ingredient, was applied by participants 2x per day in a thin layer to areas of skin laxity. | |
| Intervention type | Other | |
| Primary outcome measure(s) |
| |
| Key secondary outcome measure(s) |
| |
| Completion date | 14/08/2026 |
Eligibility
| Participant type(s) | |
|---|---|
| Age group | Mixed |
| Lower age limit | 45 Years |
| Upper age limit | 75 Years |
| Sex | Female |
| Target sample size at registration | 30 |
| Total final enrolment | 35 |
| Key inclusion criteria | Moderate to severe skin laxity on the legs and/or buttocks. |
| Key exclusion criteria | Anticipated changes to body composition through new exercise regimens, weight loss or major lifestyle changes. |
| Date of first enrolment | 13/02/2026 |
| Date of final enrolment | 14/05/2026 |
Locations
Countries of recruitment
- Australia
- United States of America
Study participating centres
Ageless Aesthetics by HB Walsh
650 Berkeley Ave
Berkeley Township
08721
United States of America
Berkeley Township
08721
United States of America
South County Microspa
195 Montana Del Lago Drive
Rancho Santa Margarita
92688
United States of America
Rancho Santa Margarita
92688
United States of America
Advanced Skin by Summer
50 Tallis Drive
Mornington
3931
Australia
Mornington
3931
Australia
Results and Publications
| Individual participant data (IPD) Intention to share | Yes |
|---|---|
| IPD sharing plan summary | Available on request |
| IPD sharing plan | All de-identified cropped images used in the analysis of efficacy endpoints to be made available to researchers. |
Editorial Notes
13/02/2026: Study’s existence confirmed by the Ageless Aesthetics by HB Walsh, USA.